
Comparator Sourcing: How to De-Risk Your Comparative Drug Supply Strategy
Roughly two-thirds of clinical trials rely on a comparator or co-therapy — and sourcing it is one of the most underestimated parts of the whole supply chain. In one industry survey, around three-quarters of respondents said they'd hit a challenge sourcing comparators or ancillaries. And the money is far from trivial: by some long-standing estimates, sponsors spend on the order of $50 million on clinical supplies for a program, with roughly half of that going to comparators.




